There has been an "impressive mortality reduction" in Chronic Kidney Disease (CKD) patients after suffering a myocardial infarction (heart attack), suggests researchers. This should come as welcomed news for CKD patients who are known to be highly susceptible to heart attacks and other cardiovascular complications.
Recommended Reading: Many with CKD die from Cardiovascular Disease instead of Kidney Disease
Over the course of twenty-four years the study found that the risk of mortality in CKD Stage 4-5, one month after having a heart attack decreased by 67% with a five year reduction for Stage 4 of 4% and Stage 5 of 10%. Among individuals with CKD Stage 2 and 3, their long-term mortality risk decreased by 15% and 20%.
Recent decades have lead to major improvements in how heart attacks are treated. Relatively new methods such as Thrombolytic Therapy (use of drugs that dissolve blood clots) and Primary Percutaneous Coronary Intervention (procedure used to treat the narrowed coronary arteries) may be a primary reason for substantially increased post-heart attack survival in those with CKD.
Although mortality after heart attack has been declining among individuals with CKD in recent decades there is still an increased risk of heart attack mortality among CKD patients as compared to the general public. One study found those with stage 4 and 5 CKD had an eight-fold higher five year mortality risk when compared to individuals with normal renal function. So KidneyBuzz.com urges you to continue to carefully monitor and take care of your heart health with manageable exercise, proper diet and taking your prescribed medication.
Like Us on our Facebook Page for more Daily News and Information about life with CKD and ESRD:https://www.facebook.com/pages/KidneyBuzz/347471888696381?ref=hl
Most Popular Stories:
"Post-Heart Attack Mortality Declining in Kidney Disease Patients." Renal and Urology
"Decline in 20-year mortality after myocardial infarction in
patients with chronic kidney disease: evolution from the
prethrombolysis to the percutaneous coronary intervention era." Kidney International